DEEP MEDICINE ACQUISITI-CL A (DMAQ) Stock Price & Overview

NASDAQ:DMAQ • US2437331026

2.96 USD
-5.43 (-64.72%)
At close: Jan 31, 2024
2.98 USD
+0.02 (+0.68%)
After Hours: 1/31/2024, 8:00:01 PM

The current stock price of DMAQ is 2.96 USD. Today DMAQ is down by -64.72%. In the past month the price decreased by -74.37%. In the past year, price decreased by -70.61%.

DMAQ Key Statistics

52-Week Range2.96 - 19.91
Current DMAQ stock price positioned within its 52-week range.
1-Month Range2.96 - 11.82
Current DMAQ stock price positioned within its 1-month range.
Market Cap
12.906M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.17
Dividend Yield
N/A

DMAQ Stock Performance

Today
-64.72%
1 Week
-66.82%
1 Month
-74.37%
3 Months
-74.59%
Longer-term
6 Months -74.37%
1 Year -70.61%
2 Years -70.07%
3 Years N/A
5 Years N/A
10 Years N/A

DMAQ Stock Chart

DEEP MEDICINE ACQUISITI-CL A / DMAQ Daily stock chart

DMAQ Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to DMAQ. When comparing the yearly performance of all stocks, DMAQ is a bad performer in the overall market: 98.64% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
DMAQ Full Technical Analysis Report

DMAQ Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to DMAQ. While DMAQ seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
DMAQ Full Fundamental Analysis Report

DMAQ Earnings

Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ1 / 2024
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
DMAQ Earnings History

DMAQ Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
DMAQ Forecast & Estimates

DMAQ Financial Highlights

Over the last trailing twelve months DMAQ reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS decreased by -466.67% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-510.00K
Industry RankSector Rank
PM (TTM) N/A
ROA -5.1%
ROE -22.17%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-500%
Sales Q2Q%N/A
EPS 1Y (TTM)-466.67%
Revenue 1Y (TTM)N/A
DMAQ financials

DMAQ Ownership

Ownership
Inst Owners7.28%
Shares4.36M
Float1.13M
Ins Owners65.87%
Short Float %N/A
Short RatioN/A
DMAQ Ownership

About DMAQ

Company Profile

DMAQ logo image Deep Medicine Acquisition Corp. is a blank check company, which aims on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Plantation, Florida. The company went IPO on 2021-10-27. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm intends to focus its search on the healthcare and education service industries. The firm is not engaged in any business operations and has not generated any revenue.

Company Info

IPO: 2021-10-27

DEEP MEDICINE ACQUISITI-CL A

7951 S.W. 6Th Street, Suite 216

Plantation FLORIDA US

Employees: 0

Phone: 19544242345

DEEP MEDICINE ACQUISITI-CL A / DMAQ FAQ

What does DEEP MEDICINE ACQUISITI-CL A do?

Deep Medicine Acquisition Corp. is a blank check company, which aims on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Plantation, Florida. The company went IPO on 2021-10-27. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm intends to focus its search on the healthcare and education service industries. The firm is not engaged in any business operations and has not generated any revenue.


What is the current price of DMAQ stock?

The current stock price of DMAQ is 2.96 USD. The price decreased by -64.72% in the last trading session.


Does DEEP MEDICINE ACQUISITI-CL A pay dividends?

DMAQ does not pay a dividend.


What is the ChartMill technical and fundamental rating of DMAQ stock?

DMAQ has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the PE ratio for DMAQ stock?

DEEP MEDICINE ACQUISITI-CL A (DMAQ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.17).


Would investing in DEEP MEDICINE ACQUISITI-CL A be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on DMAQ.